Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. - Wikidata - wikimedia - TriplyDB

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

http://www.wikidata.org/entity/Q34062737

about

Can satellite glial cells be therapeutic targets for pain control?HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain.Gene therapy for lower urinary tract dysfunction MAP kinase and pain.Nonviral retrograde gene transfer of human hepatocyte growth factor improves neuropathic pain-related phenomena in rats.Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured rats Suppression of detrusor-sphincter dyssynergia by herpes simplex virus vector mediated gene delivery of glutamic acid decarboxylase in spinal cord injured rats.Demethylating drugs as novel analgesics for cancer pain.Gene therapy for pain: results of a phase I clinical trial.Development of viral vectors for gene therapy for chronic pain Current gene therapy using viral vectors for chronic pain Vector-mediated release of GABA attenuates pain-related behaviors and reduces Na(V)1.7 in DRG neurons.Methods for gene transfer to the central nervous system.HSV vector-mediated GAD67 suppresses neuropathic pain induced by perineural HIV gp120 in rats through inhibition of ROS and Wnt5a Viral vector-based gene transfer for treatment of chronic pain.Gene therapy applications for the treatment of neuropathic pain.HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia Herpes vector-mediated gene transfer in the treatment of chronic pain Applications of gene therapy to the treatment of chronic pain.Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha.A human trial of HSV-mediated gene transfer for the treatment of chronic pain.Biomarker and pathway analyses of urine metabolomics in dairy cows when corn stover replaces alfalfa hay.HSV gene transfer in the treatment of chronic pain.Current challenges and future prospects in management of neuropathic pain.c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury?HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.A clinical trial of gene therapy for chronic pain.Targeted drug delivery to the peripheral nervous system using gene therapy.Progress in gene therapy for neurological disorders.Central nervous targets for the treatment of bladder dysfunction.Herpes simplex virus-based nerve targeting gene therapy in pain management.Herpes simplex viral vectors: late bloomers with big potential.Cell transplants to treat the "disease" of neuropathic pain and itch.Gene therapy: a potential approach for cancer pain.Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury.Ex vivo nonviral gene delivery of μ-opioid receptor to attenuate cancer-induced pain.Extracellular signal-regulated protein kinase activation in spinal cord contributes to pain hypersensitivity in a mouse model of type 2 diabetes Gene Therapy for Pain: A Perspective Adenovector GAD65 gene delivery into the rat trigeminal ganglion produces orofacial analgesia

P2860

Q24631796-A4A1A570-C2A1-46E4-A6A8-B756704CE8A6 Q25257395-20B19EE3-D406-4BA6-AEC2-C5BF6CAA12D1 Q26824783-D506B06F-AD44-4DE0-8F5D-56DF34C48AEA Q30482277-5855E3F1-9348-4D8B-A5C3-1B321865F34D Q33712995-773EC724-C93A-4336-B34B-393DF4D34924 Q33792025-49DD3A37-099A-4F8C-B3D9-80C4FF0FC416 Q33895720-FD8F1656-0A2D-474B-B814-2F18D3003BFC Q34063378-E4CF0AB5-4D23-4A72-821C-61786BAD1E18 Q34959705-C5C338AE-B534-44D6-BBD0-DDBBC3BAA054 Q35154100-EE0A58FF-DBA8-459D-A936-C5A18A8A28E9 Q35430864-47DF8D79-2AD9-478C-BD1A-23BD589FAA56 Q35658521-32CA0F19-2CE4-4C4F-B244-1929DECFD2C8 Q35875239-92EA68CF-30D8-4D35-9FF7-1D394B0A0CE1 Q35902332-54BDDA3E-454D-4F4F-B7D4-E4E9E428544F Q36777541-A2084648-D4BA-4BCA-917B-00C30593BD55 Q36787828-6D11F102-B52C-41E4-92A7-99567CBF1BD0 Q36817045-A9DBB2FC-B339-48AB-A16F-9330535321C2 Q36948465-A762D526-43FF-40C2-A542-6D0CF4DDF439 Q37035292-3DE32132-984D-4EBC-916D-81A2EC26B46C Q37108334-3CD6EB18-BBB3-4679-A38A-EDB10E173058 Q37134881-4B5FBB7A-228E-4DF7-9A0C-E79286C31BB9 Q37195741-E56039EB-24E5-4360-BED7-B79099042107 Q37220933-980D2A8C-DDC4-4F65-8429-A32F19FE022E Q37310900-0B035C56-F8B4-4401-B8C3-5D452B1F563B Q37318165-AB27A0D6-A552-4799-9AB6-C3E8BD021540 Q37412516-32AA88D0-0D21-41D8-BE24-A4A748670E9F Q37439341-DA78C456-6503-4FA9-8FCE-52AFF40623C0 Q37612033-A0881876-4A9D-494F-9A3B-AB22EB3893F8 Q38008125-52A7AB56-A9CA-41EF-89DD-F27E1EFFD196 Q38100997-487E8268-0E00-47A9-A172-FC1CBE806B95 Q38119899-3FDBD0C6-BD86-42F7-8C0A-6BD1BAFC446F Q38182564-AA7C970F-4AE7-4BC6-B0FC-B16ED3D893C9 Q38185694-A5C86F4D-CA02-42A2-BC84-B46DC9162C4A Q38701123-25CE2639-E06A-4C5E-8E90-473228F343BB Q38745962-F367E107-2DA5-4881-B5B2-DD6260A7C85B Q39955631-300D69AD-BF5C-4F92-8DC8-E903DB5600B4 Q40378943-9E2990B4-7AB1-451A-9D41-77D60834E7A0 Q41457878-171EBD14-0623-41AE-87AF-259E87627067 Q41841809-571743CE-5A60-4970-B5EA-282598E562CC Q41898238-5C993BDF-A519-4ED9-8BDF-4068CB394EF8

P2860

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

http://www.wikidata.org/entity/Q34062737

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

@ast

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

@en

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

@nl

type

label

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

@ast

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

@en

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

@nl

prefLabel

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

@ast

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

@en

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

@nl

P1433

Q34062737-600000F3-84E3-49DB-9CED-FFD17D613EE7

P1476

Q34062737-7426FE7C-4BCF-40D8-8A8F-C7F0E229A5B0

P2093

Q34062737-2AACE405-14BB-48E8-B9BF-B4F43BAFE3FD

Q34062737-2ED0C8C1-BED0-46C2-8F3C-1153F1CA9797

Q34062737-3CEE716B-0953-43EE-AA36-529BA477081F

Q34062737-8DF3DB41-C2D0-4D11-AE80-27C434FDB017

Q34062737-9B8C7D63-2601-4FF1-BF0D-0BDBA2311952

Q34062737-A4DA945D-DDD8-470E-BCDF-DE1543E27400

P2860

Q34062737-01C23E47-3FCE-4E2D-B393-5638E7C7C987

Q34062737-03660CE7-F2E2-4A1D-BC4E-2E0C1CD3D7EB

Q34062737-0FC4AB61-360A-4CD3-BAD2-5C2181A0F508

Q34062737-1C645BF4-5F0C-4501-ACC4-477B3572A86B

Q34062737-36C1D7B0-DDF0-4012-9EB2-63A1D87F7826

Q34062737-3B3B66E8-1786-40B2-B6B8-E4C672A11AF1

Q34062737-5EDBDF67-3524-425A-AC79-D8E91C86E643

Q34062737-65D5658D-534A-48A4-9FBF-BFEE5913A515

Q34062737-6FAE462B-859C-471A-AC6D-1AF91A0BFC46

Q34062737-7199654B-7606-4927-ADD4-53BEFABE8D77

P304

Q34062737-B96201D3-B74A-4A5A-8BA6-61A4B1B2B90F

P31

Q34062737-F770B7E7-40E7-43DB-8E73-9113408C977D

P356

Q34062737-F38294B8-7618-4B44-8F9A-6481081CB363

P433

Q34062737-B1083978-2FA0-4BD7-B436-7A5D711F0823

P478

Q34062737-1DB4DD31-438C-4D08-93FF-84514A6D4220

P577

Q34062737-CAB5ADB8-E559-4C08-B8BB-FE072B6DB6E8

P5875

Q34062737-47705857-DD80-4DAC-98B0-1B7421CA050E

P698

Q34062737-7B03A52B-C59F-4AB7-9795-A1ADA013C322

P921

Q34062737-0001C487-F1AF-42BB-9109-7943B39517FF

P932

Q34062737-3D29CA7C-958B-437B-82D9-EFE65B486632

P356

P1433

Annals of Neurology

P1476

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

@en

P2093

Darren Wolfe

http://www.w3.org/2001/XMLSchema#string

David J Fink

http://www.w3.org/2001/XMLSchema#string

Joseph C Glorioso

http://www.w3.org/2001/XMLSchema#string

Marina Mata

http://www.w3.org/2001/XMLSchema#string

Shaohua Huang

http://www.w3.org/2001/XMLSchema#string

Shuanglin Hao

http://www.w3.org/2001/XMLSchema#string

P2860

Quantitative assessment of tactile allodynia in the rat paw

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus.

Herpes vector-mediated gene transfer in treatment of diseases of the nervous system.

HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain.

Spinal bicuculline produces hypersensitivity of dorsal horn neurons: effects of excitatory amino acid antagonists.

Intravenous morphine does not modify dorsal horn touch-evoked allodynia in the mononeuropathic rat: a Fos study.

Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons.

Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain.

P304

914-918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.20483

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7813172

http://www.w3.org/2001/XMLSchema#string

P698

15929041

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

P932

1242042

http://www.w3.org/2001/XMLSchema#string